药店跨界卖宠物用品？疯狂的多元化战略引发行业思考
中国宠物经济爆发式增长
高盛最新报告显示，2024年中国宠物数量将首次超过4岁以下儿童数量。到2030年，中国城镇宠物数量预计突破7000万只，是幼儿数量的2倍。2023年中国宠物经济规模已达5928亿元，预计2028年将突破1.15万亿元。
Goldman Sachs reports explosive growth in China's pet economy
According to the latest Goldman Sachs report, China's pet population will surpass the number of children under 4 for the first time in 2024. By 2030, urban pets in China are expected to exceed 70 million, twice the number of young children. China's pet economy reached 592.8 billion yuan in 2023 and is projected to exceed 1.15 trillion yuan by 2028.
药店行业惊人跨界
据《中国药店》杂志报道，包括益丰、老百姓、漱玉平民等六大上市连锁药店，以及国药控股、海王星辰等年销10亿以上的大型连锁均已开始试点经营宠物用品。
Pharmacies' shocking crossover
According to China Pharmacy magazine, six listed pharmacy chains including Yifeng, Lao Bai Xing, and Shuyu Pingmin, as well as major chains with annual sales exceeding 1 billion yuan like Sinopharm Holding and Neptune have begun pilot operations of pet supplies.
行业专家强烈质疑
虽然药店多元化战略是应对"去医保化"的必要选择，但将人用药品与宠物用品混售的做法仍引发专业人士强烈质疑。有20年行业经验的专家表示："药店使命应是'为了人类健康'，而非'为了人和动物健康'。这种跨界已超出合理多元化范畴。"
Industry experts raise strong concerns
While diversification is necessary for pharmacies facing reduced medical insurance coverage, mixing human medications with pet supplies has drawn strong criticism from professionals. An expert with 20 years of experience commented: "Pharmacies' mission should be 'for human health,' not 'for human and animal health.' This crossover exceeds reasonable diversification boundaries."
法律允许但值得商榷
尽管现行法律未禁止药店销售宠物用品，但行业领军企业是否应该坚守专业定位、保持使命初心，仍是值得深思的问题。过度商业化的多元化战略可能损害药店的专业形象和公信力。
Legally permitted but debatable
While current laws don't prohibit pharmacies from selling pet supplies, whether industry leaders should maintain professional positioning and original mission remains a profound question. Over-commercialized diversification strategies may damage pharmacies' professional image and credibility.
